WALTHAM, Mass., Sept. 11, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the company has appointed Howard Rosen and Thomas Bendix Mortensen to its senior management team as it continues to grow the company's commercial operations. Mr. Rosen has joined the company as Vice President, Sales and Marketing. Previously, Mr. Rosen served as Director, Cardiovascular Service Line Franchise with Boston Scientific. Mr. Rosen's experience encompasses the successful creation and implementation of strategic marketing initiatives across a wide range of cardiovascular device franchises. Mr. Mortensen joins the company as Vice President, Sales and Marketing in Europe. Previously, Mr. Mortensen held the position of Vice President, Market Development Europe for CircuLite, Inc. and Marketing Director International – Peripheral Vascular Division for EV3. Mr. Mortensen has a strong global sales and marketing background with a particular focus in cardiovascular products and new product entries.
BG Announces Key Additions To Senior Management Team
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.